Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • c-Met/HGFR
    (1)
Filter
Search Result
Results for "

arq197

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Activity
Tivantinib
ARQ 197
T6117905854-02-6
Tivantinib (ARQ 197) is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
(3S,4S)-Tivantinib
ARQ 198,(3S,4S)-ARQ 197
T83557905854-03-7
(3S,4S)-Tivantinib, a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET, targets GSK3α and GSK3β—two novel enzymes implicated in the pathogenesis of non-small cell lung cancer (NSCLC) [1].
  • Inquiry Price
8-10 weeks
Size
QTY
(rel)-Tivantinib
(rel)-(3R,4R)-ARQ 198,(rel)-ARQ 197
T83524905853-99-8
(rel)-Tivantinib is a potent, highly selective inhibitor of the receptor tyrosine kinase c-MET and has additional novel targets, GSK3α and GSK3β, that are critical in the cellular mechanisms of non-small cell lung cancer (NSCLC) [1].
  • Inquiry Price
8-10 weeks
Size
QTY